SCHEMBL8444450

SCHEMBL8444450

COC(=O)c1cc(C(=O)OC)cc(-c2cccc3occc23)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNKS O95271 1/20 0.40
CHRM2 P08172 1/20 0.40
CHRM4 P08173 1/20 0.40
CHRM5 P08912 1/20 0.40
CHRM1 P11229 1/20 0.40
CHRM3 P20309 1/20 0.40
KMT2A Q03164 3/20 0.40
MEN1 O00255 2/20 0.40
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
CYP1A1 P04798 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP1B1 Q16678 1/20 0.39
GSK3B P49841 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
HTT P42858 1/20 0.39
CA12 O43570 2/20 0.38
CA9 Q16790 2/20 0.38
TSHR P16473 1/20 0.38
TOP2A P11388 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8442957 0.90 CHRM2 (0.49) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL8440725 0.89 CYP4F2 (0.41) TNKSCHRM2CHRM4CHRM5CHRM1
SCHEMBL8441352 0.85 FYN (0.41) CYP1A2TOP2ALMNA
SCHEMBL8442873 0.82 KEAP1 (0.43) TNKSKMT2AMEN1SMN1; SMN2TSHR
SCHEMBL8802708 0.75 KEAP1 (0.53)
SCHEMBL826486 0.74 LMNA (0.46) KMT2ACYP1A1CYP1A2CYP1B1CA12
SCHEMBL8443258 0.74 AXL (0.49) TNKSCHRM2CHRM4CHRM5CHRM1
SCHEMBL23330435 0.72 CYP1A1 (0.37) KMT2AMEN1CYP1A1CYP1A2CYP1B1
SCHEMBL2653802 0.72 LMNA (0.53) KMT2AMEN1SMN1; SMN2HTTCA12
SCHEMBL10069354 0.72 KDM4E (0.42) KMT2ACYP1A1CYP1A2CYP1B1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5968985-A INHIBITORS OF SODIUM ION/HYDROGEN ION EXCHANGE IN CELLS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-10-19 US disclosed
EP-0773927-A2 BENZOYLGUANIDINE DERIVATIVES AS MEDICAMENTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-05-21 EP disclosed
WO-1996004241-A2 BENZOYLGUANIDINE DERIVATIVES AS MEDICAMENTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-02-15 WO disclosed